New Delhi, July 15, 2021: The United States Agency for International Development (USAID)-
supported SAMRIDH Healthcare Blended Financing Facility has committed $27 million to support
India’s national health priorities, including oxygen delivery systems, cold chain storage for
vaccines, supply chain management for COVID-19 medicines, training for healthcare workers, and
other hospital and community-based activities that can be rapidly expanded to address the COVID-
19 pandemic.

Regarding USAID’s support to SAMRIDH, USAID/India Acting Mission Director, Ms. Karen
Klimowski, said: “USAID’s support to SAMRIDH reflects the United States’ strong commitment to
accelerating India’s response to the COVID-19 pandemic. Through SAMRIDH, USAID is
identifying and fast-tracking the deployment of solutions to some of the most pressing healthcare
challenges posed by the pandemic including the shortage of medical oxygen and lack of adequate
vaccine storage facilities.”

Established by USAID in 2020, the SAMRIDH Healthcare Blended Financing Facility combines
public and philanthropic funds with commercial capital to fund healthcare businesses with
innovative market-based solutions that can meet the challenges posed by the pandemic.
Implemented by IPE Global, SAMRIDH works in technical collaboration with premier institutions,
such as the Indian Institute of Technology/Delhi, the Principal Scientific Advisor to the
Government of India, the National Health Authority, and NATHEALTH.

Mr. Ashwajit Singh, Managing Director, IPE Global said, “At a time when India’s healthcare
systems are in urgent need of reinforcement, USAID’s additional support to SAMRIDH will help it
to scale-up and deploy lifesaving health solutions. Through our continuing engagement with
USAID, we support resilient and inclusive health systems, ensuring everyone has access to timely,
affordable, and quality healthcare services.”

USAID, through the SAMRIDH facility, has also recently funded healthcare enterprises that
include:

• A healthcare company that is adding beds with oxygen-delivering equipment to hospitals that serve poor and marginalized communities
• A manufacturer of low-cost defibrillators that can be used to treat heat-related emergencies in resource constrained hospitals;
• A private company addressing the continuing need for cost-effective oxygen concentrators, which turn ambient air into oxygen suitable for the treatment of severely ill COVID-19 patients.

SAMRIDH is also mobilizing additional resources from bilateral and multilateral donors,
corporations, financial institutions, and philanthropy, and adopting innovative funding mechanisms
to attract capital from the public and private sectors to support health care solutions across India.

For information about SAMRIDH please visit: www.samridhhealth.org
Point of Contact:
Vinaina Suri
Mob: 91- 9711335883
Email: vsuri@ipeglobal.com
For more information on USAID’s India Health Initiatives please visit:
https://www.usaid.gov/india